Stay updated on MK-2870-004 Clinical Trial
Sign up to get notified when there's something new on the MK-2870-004 Clinical Trial page.

Latest updates to the MK-2870-004 Clinical Trial page
- Check2 days agoChange DetectedA new study site, Tennessee Oncology Chattanooga (Site 0038) in Chattanooga, Tennessee, was added, bringing the total number of locations to 195. This expansion increases patient access to the study.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page now displays Revision: v3.6.5 and has removed the Plain Language Summary as well as the previous Revision: v3.6.4, indicating an update to the page's revision metadata.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating an incremental release of the site. No visible content changes for the study details are described in the provided changes.SummaryDifference0.0%

- Check30 days agoChange DetectedJuly 2026 update dates were added to the study record and June 2026 dates were removed, updating the record's modification history to reflect recent changes.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page revision updated from v3.6.2 to v3.6.3, indicating a new version of the study record. This likely reflects minor edits or corrections to the page.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.6.2 is now shown on the page, indicating an updated version of the page. This reflects a minor revision to the page rather than a substantive content change.SummaryDifference0.0%

Stay in the know with updates to MK-2870-004 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-2870-004 Clinical Trial page.